Last reviewed 2026-04-19 · How we verify

DNL952

Denali Therapeutics Inc. · Phase 1 active Small molecule

At a glance

Generic name	DNL952
Sponsor	Denali Therapeutics Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.